Basit öğe kaydını göster

Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization

dc.contributor.authorKoksal, N
dc.contributor.authorPerk, Y
dc.contributor.authorAltinkaya, N
dc.date.accessioned2021-03-05T12:08:03Z
dc.date.available2021-03-05T12:08:03Z
dc.date.issued1996
dc.identifier.citationKoksal N., Altinkaya N., Perk Y., "Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization", ACTA PAEDIATRICA, cilt.85, ss.1501-1502, 1996
dc.identifier.issn0803-5253
dc.identifier.otherav_aba94ff0-81dd-47c9-8cfe-c2cf1e80b0fa
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/114581
dc.identifier.urihttps://doi.org/10.1111/j.1651-2227.1996.tb13961.x
dc.description.abstractFollowing immunization with hepatitis B vaccine, 39 infants were followed prospectively for hepatitis B surface antigen (HBsAg). A total of 69.2% of the infants tested positive for antigenemia at least once. Antigenemia was identified most often at 2-3 days (43.5%) and 5-6 days (43.5%) after immunization. The longest documented duration of antigenemia was 21 days. In all cases the antigenemia was transient and cleared by the 28th day post-vaccination.
dc.language.isoeng
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectPEDİATRİ
dc.titleTransient hepatitis B surface antigenemia after neonatal hepatitis B immunization
dc.typeMakale
dc.relation.journalACTA PAEDIATRICA
dc.contributor.department, ,
dc.identifier.volume85
dc.identifier.issue12
dc.identifier.startpage1501
dc.identifier.endpage1502
dc.contributor.firstauthorID118133


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster